Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatin for relapsed metastatic breast cancer: A phase II study

Daniel J. Booser, Ronald S. Walters, Frankie A. Holmes, Gabriel N. Hortobagyi

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Twelve women with metastatic breast cancer were treated with continuous infusion high dose leucovorin, 5-fluorouracil and cisplatin. Toxicity was severe although the dose was lower than previously described for the treatment of other cancers, and there was little anti-tumor activity. Many other regimens are more effective and less toxic.

Original languageEnglish (US)
Pages (from-to)40-41
Number of pages2
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume23
Issue number1
DOIs
StatePublished - Feb 2000

Keywords

  • 5-FU
  • Breast cancer
  • Cisplatin
  • Leucovorin
  • Relapse

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatin for relapsed metastatic breast cancer: A phase II study'. Together they form a unique fingerprint.

Cite this